Trials / Completed
CompletedNCT04254913
Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the pharmacokinetics of single doses of edaravone oral suspension in Amyotrophic Lateral Sclerosis Patients with gastrostomy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-1186 | Suspension |
Timeline
- Start date
- 2020-01-24
- Primary completion
- 2020-04-16
- Completion
- 2020-04-22
- First posted
- 2020-02-05
- Last updated
- 2026-01-07
- Results posted
- 2024-01-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04254913. Inclusion in this directory is not an endorsement.